{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:45:22Z","timestamp":1777477522533,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL007101"],"award-info":[{"award-number":["5T32HL007101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL069749"],"award-info":[{"award-number":["5T32HL069749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17MCPRP33460225"],"award-info":[{"award-number":["17MCPRP33460225"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL084904"],"award-info":[{"award-number":["U10 HL084904"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110302"],"award-info":[{"award-number":["U10 HL110302"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110338"],"award-info":[{"award-number":["U10 HL110338"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110262"],"award-info":[{"award-number":["U10 HL110262"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110336"],"award-info":[{"award-number":["U10 HL110336"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110337"],"award-info":[{"award-number":["U10 HL110337"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110342"],"award-info":[{"award-number":["U10 HL110342"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110309"],"award-info":[{"award-number":["U10 HL110309"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110312"],"award-info":[{"award-number":["U10 HL110312"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U10 HL110297"],"award-info":[{"award-number":["U10 HL110297"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006795","name":"Heart Failure Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ahj.2019.11.006","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:56:46Z","timestamp":1573847806000},"page":"97-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?"],"prefix":"10.1016","volume":"220","author":[{"given":"Marat","family":"Fudim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar F.","family":"AbouEzzeddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh N.V.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Alhanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.ahj.2019.11.006_bb0005","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/jama.2009.681","article-title":"Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis","volume":"301","author":"Kodama","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","article-title":"Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure","volume":"83","author":"Mancini","year":"1991","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.006_bb0015","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/CIRCULATIONAHA.109.914788","article-title":"Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease","volume":"123","author":"Arena","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ahj.2019.11.006_bb0020","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.1993.03510140062030","article-title":"Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators","volume":"270","author":"Bittner","year":"1993","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ahj.2019.11.006_bb0025","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","article-title":"Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association","volume":"134","author":"Ross","year":"2016","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ahj.2019.11.006_bb0030","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.006_bb0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jchf.2014.06.013","article-title":"Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury","volume":"3","author":"Ahmad","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2015.10.079","article-title":"Prognostic implications of long-chain acylcarnitines in heart failure and reversibility with mechanical circulatory support","volume":"67","author":"Ahmad","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2019.11.006_bb0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCHEARTFAILURE.111.965186","article-title":"Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training","volume":"5","author":"Swank","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ahj.2019.11.006_bb0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.ahj.2019.11.006_bb0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide\u2013guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.006_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jchf.2018.10.014","article-title":"NT-proBNP goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF","volume":"7","author":"Daubert","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.ahj.2019.11.006_bb0065","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2017.11.070","article-title":"Effect of NT-proBNP\u2013guided therapy on all-cause mortality in chronic heart failure with reduced ejection fraction","volume":"71","author":"Bajaj","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.006_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.006_bb0075","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0735-1097(02)02032-6","article-title":"Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure","volume":"40","author":"Kruger","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijcard.2006.10.016","article-title":"B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure","volume":"120","author":"Maeder","year":"2007","journal-title":"Int J Cardiol"},{"issue":"19","key":"10.1016\/j.ahj.2019.11.006_bb0085","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.006_bb0090","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ahj.2019.11.006_bb0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCHEARTFAILURE.112.969071","article-title":"PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design","volume":"5","author":"Redfield","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ahj.2019.11.006_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.000345","article-title":"Oral iron therapy for heart failure with reduced ejection fraction: design and rationale for oral iron repletion effects on oxygen uptake in heart failure","volume":"9","author":"Lewis","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.ahj.2019.11.006_bb0105","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0300-8932(10)70249-9","article-title":"Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure","volume":"63","author":"Bayes-Genis","year":"2010","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","article-title":"GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation","volume":"98","author":"Xu","year":"2006","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ Res"},{"issue":"19","key":"10.1016\/j.ahj.2019.11.006_bb0120","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jchf.2013.12.004","article-title":"Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure","volume":"2","author":"Ahmad","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"14","key":"10.1016\/j.ahj.2019.11.006_bb0130","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.006_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejim.2005.11.001","article-title":"The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure","volume":"17","author":"Kruger","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.ahj.2019.11.006_bb0140","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","article-title":"Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure","volume":"38","author":"Koglin","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2019.11.006_bb0145","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of growth differentiation factor-15, a marker of oxidative stress and inflammation, in chronic heart failure: insights from the HF-ACTION study","volume":"5","author":"Sharma","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.006_bb0150","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCHEARTFAILURE.113.000207","article-title":"Soluble ST2 in ambulatory patients with heart failure: association with functional capacity and long-term outcomes","volume":"6","author":"Felker","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.006_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","author":"de Boer","year":"2012","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amjcard.2011.03.056","article-title":"Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival","volume":"108","author":"Tang","year":"2011","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.006_bb0165","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/eurjhf\/hfq151","article-title":"The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction","volume":"12","author":"Stahrenberg","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.006_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","article-title":"Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction","volume":"55","author":"Weir","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.006_bb0180","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/euhj.2000.2310","article-title":"Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?","volume":"22","author":"Opasich","year":"2001","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.006_bb0185","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.006_bb0190","first-page":"4781","article-title":"The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women","volume":"85","author":"Moore","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.006_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jchf.2014.10.009","article-title":"Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure)","volume":"3","author":"AbouEzzeddine","year":"2015","journal-title":"JACC Heart Fail"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:58:50Z","timestamp":1777384730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319303072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":39,"alternative-id":["S0002870319303072"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.11.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}